OBJECTIVE -To investigate the association of variants of the intestinal fatty acid-binding protein gene (FABP2) with fasting and postchallenge glucose and insulin levels, HbA 1c , and prevalence of type 2 diabetes in a separate sample of men and women.RESEARCH DESIGN AND METHODS -Subjects were participants in the Framingham Offspring Study, a long-term community-based prospective observational study of risk factors for cardiovascular disease. The study sample consisted of 762 men and 922 women.RESULTS -In women, carriers of the thr54 allele had significantly higher 2-h postchallenge insulin levels than noncarriers (104.4 Ϯ 73.0 vs. 93.4 Ϯ 61.5 U/ml; P ϭ 0.0139). This relationship remained significant after adjustment for familial relationship, age, BMI, triglycerides, APOE genotype, smoking, alcohol intake, the use of -blockers, menopausal status, and estrogen therapy. No such significant association was observed in men. In both men and women, there were no statistical associations between the FABP2 polymorphism and BMI, fasting glucose, fasting insulin, 2-h postchallenge glucose levels, HbA 1c , and prevalence of type 2 diabetes.CONCLUSIONS -These results suggest that the FABP2 thr54 allele may have a minor contribution to the insulin resistance syndrome in a white general population.
Diabetes Care 24:1161-1166, 2001F atty acid metabolism has been linked to insulin resistance since Randle et al. (1) proposed the glucose-fatty acid cycle 38 years ago. The intestinal fatty acid-binding protein (IFABP) is a member of the family of cytoplasmic fatty acid-binding proteins. It is synthesized exclusively in the intestine and is involved with the transport and metabolism of saturated and unsaturated long-chain fatty acids (LCFAs) (2,3). The intestinal fatty acid-binding protein gene (FABP2) located at chromosome 4q28-31 is a candidate gene possibly implicated in insulin resistance and the pathogenesis of type 2 diabetes.In 1995, Baier et al. (4) discovered a G 3 A mutation at codon 54 of FABP2, resulting in an amino acid substitution in IFABP, ala54 (wild-type) 3 thr54 (mutant-type). This amino acid substitution was first found to be associated with elevated fasting insulin levels, insulin resistance, and a higher mean fat oxidation rate in Pima Indians without type 2 diabetes (4). In vitro studies have found that the mutated thr54 IFABP has greater affinity for LCFAs than the wild-type ala54 IFABP, and it transports LCFAs and secretes triglycerides (TGs) and cholesterol esters to a greater degree than wild-type IFABP (4,5), suggesting that this ala54thr substitution is in fact a functional mutation.Several studies have found significant associations between the FABP2 gene and type 2 diabetes or phenotypes associated with impaired glucose tolerance (4,6 -9). Conversely, other studies have failed to find significant associations between the FABP2 gene and type 2 diabetes or related phenotypes (10 -22). Moreover, a study of Keewatin Inuit (Eskimos) found the thr54 allele to be associated with lower 2-h glucose concentra...